Chimerix Stock EBITDA

CMRX Stock

USD 8.47 0.01 0.12%

Chimerix fundamentals help investors to digest information that contributes to Chimerix's financial success or failures. It also enables traders to predict the movement of Chimerix Stock. The fundamental analysis module provides a way to measure Chimerix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chimerix stock.

		Last Reported	Projected for Next Year
	EBITDA	-83.7 M	-87.9 M

EBITDA is likely to drop to about (87.9 M) in 2025.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Chimerix Company EBITDA Analysis

Chimerix's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Chimerix EBITDA

(92.97 M)

Most of Chimerix's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chimerix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Chimerix EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Chimerix is extremely important. It helps to project a fair market value of Chimerix Stock properly, considering its historical fundamentals such as EBITDA. Since Chimerix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chimerix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chimerix's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	-0.32	-0.28	0.56	-0.59	-0.26	0.91	0.11	0.97	-0.23	0.48	0.45	0.94	-0.13	0.57	-0.54	0.38	-0.09	0.35	0.44	0.18
Total Stockholder Equity	1.0		-0.33	-0.27	0.56	-0.59	-0.25	0.9	0.05	0.97	-0.27	0.45	0.44	0.94	-0.12	0.55	-0.54	0.38	-0.1	0.36	0.44	0.15
Net Debt	-0.32	-0.33		-0.22	-0.12	0.13	0.49	0.02	0.31	-0.42	-0.01	0.09	0.04	-0.23	-0.06	0.08	-0.28	0.04	0.11	-0.16	-0.15	0.3
Retained Earnings	-0.28	-0.27	-0.22		0.3	0.61	0.48	-0.5	-0.34	-0.38	-0.12	-0.91	0.02	-0.08	0.34	-0.91	0.86	0.58	-0.79	0.55	0.09	-0.78
Accounts Payable	0.56	0.56	-0.12	0.3		-0.27	0.32	0.41	0.09	0.41	-0.18	-0.2	0.62	0.63	0.14	-0.07	-0.04	0.71	-0.49	0.35	0.16	-0.36
Long Term Debt	-0.59	-0.59	0.13	0.61	-0.27		0.05	-0.62	-0.04	-0.61	0.22	-0.56	-0.3	-0.45	0.17	-0.71	0.67	0.16	-0.31	0.24	-0.01	-0.34
Net Receivables	-0.26	-0.25	0.49	0.48	0.32	0.05		-0.16	-0.13	-0.39	-0.42	-0.55	0.06	-0.03	0.11	-0.46	0.28	0.44	-0.43	0.35	0.1	-0.28
Short Term Investments	0.91	0.9	0.02	-0.5	0.41	-0.62	-0.16		0.19	0.9	-0.27	0.66	0.39	0.87	-0.17	0.75	-0.76	0.2	0.12	0.25	0.47	0.42
Total Liab	0.11	0.05	0.31	-0.34	0.09	-0.04	-0.13	0.19		0.09	0.65	0.46	0.17	0.06	-0.17	0.38	-0.18	0.02	0.29	-0.03	0.03	0.64
Total Current Assets	0.97	0.97	-0.42	-0.38	0.41	-0.61	-0.39	0.9	0.09		-0.19	0.58	0.33	0.88	-0.17	0.65	-0.57	0.16	0.08	0.29	0.49	0.28
Short Term Debt	-0.23	-0.27	-0.01	-0.12	-0.18	0.22	-0.42	-0.27	0.65	-0.19		0.15	0.28	-0.36	0.13	0.03	0.12	-0.21	0.09	-0.35	-0.48	0.18
Common Stock	0.48	0.45	0.09	-0.91	-0.2	-0.56	-0.55	0.66	0.46	0.58	0.15		0.0	0.32	-0.24	0.96	-0.8	-0.43	0.69	-0.31	0.13	0.85
Property Plant Equipment	0.45	0.44	0.04	0.02	0.62	-0.3	0.06	0.39	0.17	0.33	0.28	0.0		0.4	0.28	0.09	-0.3	0.4	-0.5	-0.03	-0.29	-0.29
Net Tangible Assets	0.94	0.94	-0.23	-0.08	0.63	-0.45	-0.03	0.87	0.06	0.88	-0.36	0.32	0.4		-0.01	0.42	-0.39	0.51	-0.24	0.55	0.57	0.09
Long Term Debt Total	-0.13	-0.12	-0.06	0.34	0.14	0.17	0.11	-0.17	-0.17	-0.17	0.13	-0.24	0.28	-0.01		-0.3	0.25	0.12	-0.46	0.0	-0.21	-0.47
Capital Surpluse	0.57	0.55	0.08	-0.91	-0.07	-0.71	-0.46	0.75	0.38	0.65	0.03	0.96	0.09	0.42	-0.3		-0.85	-0.39	0.65	-0.3	0.13	0.78
Current Deferred Revenue	-0.54	-0.54	-0.28	0.86	-0.04	0.67	0.28	-0.76	-0.18	-0.57	0.12	-0.8	-0.3	-0.39	0.25	-0.85		0.25	-0.48	0.31	-0.07	-0.55
Long Term Investments	0.38	0.38	0.04	0.58	0.71	0.16	0.44	0.2	0.02	0.16	-0.21	-0.43	0.4	0.51	0.12	-0.39	0.25		-0.78	0.68	0.26	-0.43
Short Long Term Debt	-0.09	-0.1	0.11	-0.79	-0.49	-0.31	-0.43	0.12	0.29	0.08	0.09	0.69	-0.5	-0.24	-0.46	0.65	-0.48	-0.78		-0.52	0.04	0.77
Net Invested Capital	0.35	0.36	-0.16	0.55	0.35	0.24	0.35	0.25	-0.03	0.29	-0.35	-0.31	-0.03	0.55	0.0	-0.3	0.31	0.68	-0.52		0.81	-0.18
Net Working Capital	0.44	0.44	-0.15	0.09	0.16	-0.01	0.1	0.47	0.03	0.49	-0.48	0.13	-0.29	0.57	-0.21	0.13	-0.07	0.26	0.04	0.81		0.22
Capital Stock	0.18	0.15	0.3	-0.78	-0.36	-0.34	-0.28	0.42	0.64	0.28	0.18	0.85	-0.29	0.09	-0.47	0.78	-0.55	-0.43	0.77	-0.18	0.22

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Chimerix

Ebitda Over Time

Chimerix Ebitda

Ebitda

(87.86 Million)

Chimerix reported EBITDA of (83.68 Million) in 2024

According to the company disclosure, Chimerix reported earnings before interest,tax, depreciation and amortization of (92.97 Million). This is 110.6% lower than that of the Biotechnology sector and 192.83% lower than that of the Health Care industry. The ebitda for all United States stocks is 102.38% higher than that of the company.

Chimerix EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chimerix's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chimerix could also be used in its relative valuation, which is a method of valuing Chimerix by comparing valuation metrics of similar companies.

Chimerix is currently under evaluation in ebitda category among its peers.

Chimerix Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chimerix from analyzing Chimerix's financial statements. These drivers represent accounts that assess Chimerix's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chimerix's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	300.3M	546.1M	162.9M	85.3M	98.1M	93.2M
Enterprise Value	256.2M	547.1M	139.1M	58.9M	67.8M	64.4M

Chimerix ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Chimerix's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Chimerix's managers, analysts, and investors.

Environmental

Governance

Social

Chimerix Institutional Holders

Institutional Holdings refers to the ownership stake in Chimerix that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chimerix's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chimerix's value.

		Shares
Geode Capital Management, Llc	2024-12-31	836.7 K
Renaissance Technologies Corp	2024-12-31	820.3 K
Assenagon Asset Management Sa	2024-12-31	817.7 K
Blackrock Inc	2024-12-31	814.8 K
Peapod Lane Capital Llc	2024-12-31	754.6 K
Citadel Advisors Llc	2024-12-31	729.3 K
Northern Trust Corp	2024-12-31	549.8 K
Goldman Sachs Group Inc	2024-12-31	497.2 K
Connor Clark & Lunn Inv Mgmt Ltd	2024-12-31	429.5 K
Ra Capital Management, Llc	2024-12-31	8.8 M
Vanguard Group Inc	2024-12-31	4 M

Chimerix Fundamentals

	Return On Equity	-0.49
	Return On Asset	-0.3
	Operating Margin	(953.58) %
	Current Valuation	651.59 M
	Shares Outstanding	93.05 M
	Shares Owned By Insiders	6.74 %
	Shares Owned By Institutions	52.90 %
	Number Of Shares Shorted	4.14 M
	Price To Earning	(3.43) X
	Price To Book	5.80 X
	Price To Sales	4,951 X
	Revenue	324 K
	Gross Profit	(73.39 M)
	EBITDA	(92.97 M)
	Net Income	(82.09 M)
	Cash And Equivalents	42.79 M
	Cash Per Share	0.49 X
	Total Debt	1.3 M
	Debt To Equity	0.1 %
	Current Ratio	2.18 X
	Book Value Per Share	1.51 X
	Cash Flow From Operations	(69.09 M)
	Short Ratio	2.65 X
	Earnings Per Share	(0.94) X
	Target Price	8.54
	Number Of Employees	72
	Beta	0.32
	Market Capitalization	787.18 M
	Total Asset	212.77 M
	Retained Earnings	(795.52 M)
	Working Capital	170.67 M
	Current Asset	228.84 M
	Current Liabilities	20.18 M
	Net Asset	212.77 M

About Chimerix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chimerix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chimerix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chimerix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

Additional Tools for Chimerix Stock Analysis

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC